Supo – Aromasin® Exemestane 25mg
Brand Name : Beligas
Active Ingredient : Exemestane
Tablet Count : 100 Tablets
Dosage : 25mg
Aromasin ® 25mg 50tabs
ACTIVE INGREDIENT: EXEMESTANE 25mg
TABLET COUNT: 50 COUNTS
ACTIVE HALF-LIFE: 9 HOURS
CLASSIFICATION: ANABOLIC STEROID
DOSAGE MEN: 25-50 MG/DAY
DOSAGE WOMEN: 5-30 MG/DAY
ACNE: RARELY
WATER RETENTION: NO
HBR: NO
HEPATOXITY: LOW
AROMATIZATION: NO
Arimedex 1mg (Adex 1)
Active Half-Life: Approximately 46 hours
Classification: Aromatase Inhibitor
Dosage: 0.5-1 mg
Acne: Unlikely
Water Retention: Unlikely
HBR (High Blood Pressure): Unlikely
Hepatotoxicity: Low
Aromatization: None
Ultima-Anastro 1-USA
ACTIVE HALF-LIFE: 2 days
CLASSIFICATION: Non-steroidal aromatase inhibitor
DOSAGE: 0.5-1 mg/day
ACNE: No
WATER RETENTION: No
HBR: No
HEPATOTOXICITY: No
AROMATIZATION: No
MANUFACTURER: Ultima Pharmaceuticals – US
WAREHOUSE: USA Warehouse 9
SUBSTANCE: Anastrozole,
Arimimed 1mg – Anastrozole – Deus Medical
Active: (anastrozole) Tabs
Molar mass: 293.366 g/mol
CAS ID: 120511-73-1
Formula: C17H19N5
Elimination half-life: 46.8 hours
Trade name: Arimidex, others
Metabolism: Liver (85%)
ARIMIROW 1 mg/50 tabs (Anastrozole)
MAIN SUBSTANCE: ANASTROZOLEFORM: ORAL
TAB PIECE: 50 Tabs
PACK: BOTTLE
DOSAGE: 1 MG
DOSAGE UNIT: TABS
EAN13: 1371849859715
REFERENCE: CRX018
Arimidex® Anastrozole 1mg
Active: ANASTROZOLE Tablets
Dosage: 1mg/tab
Tablet Count: 50 tablets
Formula: C17H19N5
Elimination half-life: 46.8 hours
Trade name: Arimidex, others
Metabolism: Liver (85%)
Acne: RARELY
Water Retention: NO
HBR: NO
Hepatoxity: LOW
Aromatization: YES
Ultima-Stan 25mg-int
ACTIVE HALF-LIFE: 8 Hours
CLASSIFICATION: Anabolic Steroid
DOSAGE: 20-50 mg/day
ACNE: Yes
WATER RETENTION: No
HBR: Perhaps
HEPATOTOXICITY: High
AROMATIZATION: No
Aramidex 1 (30 Tablets) – American Brand
Active: ANASTROZOLE Tablets
Dosage: 1mg/tab
Tablet Count: 30 tablets
Formula: C17H19N5
Elimination half-life: 46.8 hours
Trade name: Arimidex, others
Metabolism: Liver (85%)
Acne: RARELY
Water Retention: NO
HBR: NO
Hepatoxity: LOW
Aromatization: YES
